Tag: PixarBio
Securities and Exchange Commission temporarily suspends trade of PixarBio stock
PixarBio stock has been suspended from trade by the Securities and Exchange Commission, in line with the Securities Exchange Act of 1934. The Commission...
InVivo Therapeutics clashes with PixarBio over proposed takeover
Invivo Therapeutics has rebuked a press release from PixarBio claiming that it had made a US$77,000,000 stock offer to acquire the company.
The colourfully-worded release,...
PixarBio establishes research centre focusing on spinal cord injury treatment
PixarBio—developers of NeuroRelease, a morphine replacement, non-opioid pain treatment—has established the JP Reynolds Research Center in Woburn, USA.
The lab will focus on research and...